Skip to content

Clinical trials

Phase 1/2 Staphylococcal Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Staphylococcal Infections Phase: Phase 1/2 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20121
20141
20151
20171
20211
20222
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AM-Pharma1
Aridis Pharmaceuticals, Inc.1
Armata Pharmaceuticals, Inc.1
AstraZeneca1
Centre Hospitalier Universitaire de Nīmes1
Destiny Pharma Plc1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
MB PHARMA s.r.o.1
Nabi Biopharmaceuticals1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Staphylococcal Infections14
Bacteremia3
Pseudomonas Infections3
Diabetic Foot2
Acinetobacter Infections1
Bacterial Infections1
Dermatitis, Atopic1
Kidney Failure, Chronic1
Pneumonia1
Pressure Ulcer1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.